Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 08, 2021
Xylyx Bio and Cell&Soft announced positive preliminary results, reaching a key milestone in their partnership to develop more physiologically relevant in vitro cellular models for cell-based assays in oncology.
read more
Monday, February 08, 2021
Immunome announced that Abzena was selected as Immunome’s partner research organization for IMM-BCP-01, an investigational therapeutic antibody cocktail for the treatment of COVID-19 being developed to target multiple SARS-CoV-2 antigens.
read more
Monday, February 08, 2021
X-Chem has entered into a research collaboration and license agreement with Genentech.
read more
Monday, February 08, 2021
Emmes announced progress in its role as Data Coordinating Center for studies conducted under the Best Pharmaceuticals for Children Act (BPCA).
read more
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Monday, February 08, 2021
Noble has announced the launch of “Human Factors Plus” (HF+), an expanded service to further optimize the patient self-administration experience by supporting its customers.
read more
Friday, February 05, 2021
Reflect Scientific has announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration.
read more
Friday, February 05, 2021
CureVac and Rentschler Biopharma announced the companies have initiated the set-up of manufacturing capabilities for CureVac´s COVID-19 vaccine, CVnCoV.
read more
Friday, February 05, 2021
Moleculin Biotech has signed an agreement with Catalyst to manage its US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma that has metastasized to the lungs.
read more
Friday, February 05, 2021
Sepha has launched a contract packaging service for small batch production.
read more
Wednesday, February 03, 2021
Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
read more
Wednesday, February 03, 2021
Meitheal Pharmaceuticals is voluntarily recalling one (1) lot of Cisatracurium Besylate Injection, USP 10mg per 5mL to the user level.
read more
Wednesday, February 03, 2021
Lonza has expanded its human primary cell offerings with the launch of fully customizable cryopreserved Leukopaks.
read more
Wednesday, February 03, 2021
Novartis has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting the production of the Pfizer-BioNTech COVID-19 Vaccine.
read more
Wednesday, February 03, 2021
Worldwide Clinical Trials announced the appointment of Peter Lammers as Executive Vice President, Global Marketing and Commercial Operations.
read more